The Role of Pharmaceutical Innovation in Clinical Practice Guidelines for Chronic Diseases.

ABSTRACT:

Background

Over the last 25 years, clinical practice guidelines have emerged as a means to standardize and improve care. As pharmaceutical innovations develop, guidelines are updated to incorporate new interventions. However, the extent to which pharmacotherapies are represented as treatment options in guideline recommendations has not been well elucidated. This study aimed to quantify the role pharmacotherapy has played in clinical practice guidelines across a range of chronic diseases over the past 20 years.

Methods

Clinical practice guidelines published from 2000 to 2021 were identified for five chronic diseases: ischemic heart disease (IHD), non-small cell lung cancer (NSCLC), chronic obstructive pulmonary disease (COPD), Alzheimer's disease (AD), and type 2 diabetes (T2

SUBMITTER: Roach M 

PROVIDER: S-EPMC10950408 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature